TotalMarketCap

Longeveron

LGVNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.516 M

$1.73 -2.81%

Close of 6 Nov 2026

As of 6 Nov 2026, Longeveron (LGVN) has a market capitalization of $5.52M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.20M

#3447 by revenue

Earnings

-$22.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #443ExicureXCUR$5.83M
  2. #444Bio Green Med SolutionBGMS$5.76M
  3. #445LongeveronLGVN$5.52M
  4. #446Acurx PharmaceuticalsACXP$5.39M
  5. #447Jaguar HealthJAGX$5.35M

What if Longeveron were worth as much as…

Open the what-if tool →

Gold $28.2T

$8,856,685

Per share 5,119,471× higher

Bitcoin $1.53T

$479,219.82

Per share 277,006× higher

Apple $5.02T

$1,573,234

Per share 909,384× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Longeveron are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.